Non categorizzato Astellas Pharma acquires Iveric Bio for $5.9 billion Maggio 1, 2023 0 commenti Japanese giant Astellas Pharma Inc. announced on Monday it has reached an agreement to acquire the entire stake of American biopharma company Iveric Bio for $5.9 billion or $40 per share in cash. The… About the author:
Get involved!
Comments